These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38666475)

  • 1. Population Pharmacokinetics of Lamotrigine and Its N2-Glucuronide Metabolite in Chinese Patients With Epilepsy.
    Yang H; Zhang D; Wei S; Zhao Z; Mei S
    Ther Drug Monit; 2024 Oct; 46(5):649-657. PubMed ID: 38666475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
    Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
    Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic Models.
    Tauzin M; Tréluyer JM; Nabbout R; Billette de Villemeur T; Desguerre I; Aboura R; Gana I; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D
    J Clin Pharmacol; 2021 May; 61(5):677-687. PubMed ID: 33244764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
    Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X
    J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.
    He DK; Wang L; Qin J; Zhang S; Lu W; Li L; Zhang JM; Bao WQ; Song XQ; Liu HT
    Acta Pharmacol Sin; 2012 Nov; 33(11):1417-23. PubMed ID: 23103620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
    Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
    Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
    Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
    Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
    Zhang S; Wang L; Lu W
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
    Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
    PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy.
    Chávez-Castillo CE; Medellín-Garibay SE; Milán-Segovia RDC; Rodríguez-Leyva I; Romano-Moreno S
    J Pharm Sci; 2020 Sep; 109(9):2902-2908. PubMed ID: 32534880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Li X; Wei S; Wu H; Zhang Q; Zhao Z; Mei S; Feng W; Wu Y
    Eur J Pediatr; 2023 Oct; 182(10):4509-4521. PubMed ID: 37493972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
    Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L
    Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
    Gu X; Zhu M; Sheng C; Yu S; Peng Q; Ma M; Hu Y; Li Z; Jiao Z; Zhou B
    Eur J Clin Pharmacol; 2021 Jul; 77(7):999-1009. PubMed ID: 33423079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen.
    Lin WW; Jiao Z; Wang CL; Wang HY; Ma CL; Huang PF; Guo XZ; Liu YW
    Ther Drug Monit; 2015 Feb; 37(1):76-83. PubMed ID: 24831653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of valproate in Chinese children with epilepsy.
    Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR
    Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
    Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
    J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of topiramate in Chinese children with epilepsy.
    Wei S; Li X; Zhang Q; Wu H; Wu Y; Zhao Z; Mei S; Feng W
    Eur J Clin Pharmacol; 2023 Oct; 79(10):1401-1415. PubMed ID: 37597080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
    Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
    Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients--nonlinear mixed effects modelling approach.
    Brzaković B; Vučićević K; Kovačević SV; Miljković B; Prostran M; Martinović Ž; Pokrajac M
    Eur J Clin Pharmacol; 2014 Feb; 70(2):179-85. PubMed ID: 24240511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery.
    Wu R; Li K; Zhao Z; Mei S
    Eur J Clin Pharmacol; 2024 Nov; 80(11):1819-1828. PubMed ID: 39210212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.